Dentsply Sirona

DENTSPLY SIRONA INC. (NASDAQ: XRAY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

Retrieved on: 
Tuesday, July 19, 2022
Audit committee, SEC, News, District court, Investment, Sirona, Disclosure, Advertising, Labour government, GLOBE, Securities Exchange Act of 1934, Technology, Dentsply Sirona, The Legal 500, Committee on Finance, Degenerative disease, Lists of action films, Board of directors, NASDAQ, NEW, Board, Company, COVID-19, XRAY, Class, Court, Anesthetic, Audit, Plaque, Defendant, Achievement, Tobacco, Security (finance)

NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Ohio and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Dentsply produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
  • As (former) executives of Dentsply, Defendants Donald M. Casey, Jr. (Casey) and Jorge Gomez (Gomez) were eligible for significant cash- and stock-based incentive compensation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY

Retrieved on: 
Sunday, July 17, 2022
LLP, GLOBE, News, NASDAQ, Pomerantz, Company, Dentsply Sirona, XRAY, Private investigator

NEW YORK, July 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (Dentsply Sirona or the Company) (NASDAQ: XRAY).

Key Points: 
  • NEW YORK, July 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (Dentsply Sirona or the Company) (NASDAQ: XRAY).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Dentsply Sirona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP, and Dentsply Sirona and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, July 16, 2022
News, Audit committee, LMP, Spero, Review, Board, Kidney, Company, Government, California superior courts, Population, Medicare, SEC, Dentsply Sirona, Relevant, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Annual report, Food, Income, Complaint, NASDAQ, Physician, Anesthetic, Defendant, Patient, Class Action, Urinary tract infection, Lists of schools in England, Tebipenem, CDNA, Superior, Degenerative disease, COVID-19, XRAY, NDA, Risk, Growth, Plaque, Workforce, Justice, Mission statement, GLOBE, Complicated, New Drug Application, Marketing, Documentation, Infection, Sale, FDA, ASP, Treatment, HBR, Pharmaceutical industry, Animal, Renewable energy, Audit, Medical device, Property management, P.C, Pyelonephritis

Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.

Key Points: 
  • Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the Class Period.
  • For more information on the Dentsply Sirona class action go to: https://bespc.com/cases/XRAY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages DENTSPLY SIRONA Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY

Retrieved on: 
Saturday, July 16, 2022
Titan, Advertising, Dentsply Sirona, SEC, WHY, Facebook, THE, LinkedIn, Sirona, I-Space (Chinese company), GLOBE, Twitter, Lists of schools in England, GAAP, NASDAQ, Class, XRAY, TO, Court, Insurance, Tobacco

WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Dentsply Sirona Inc. (XRAY) Investors and Encourages Investors to Contact the Firm Before August 1, 2022

Retrieved on: 
Friday, July 15, 2022
SEC, News, CEO, District court, Audit committee, Late, Director, GLOBE, Technology, Lists of schools in England, Kirby, Degenerative disease, NASDAQ, Board, XRAY, Company, Court, Anesthetic, Dentsply Sirona, Plaque, Douglas v. U.S. District Court ex rel Talk America, Private investigator, Online gambling

Investors have until August 1, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until August 1, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Dentsply Sirona produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
  • On April 19, 2022, Dentsply Sirona announced the sudden termination of Defendant Casey as CEO and as a member of the Board of Directors.
  • Dentsply Sirona and its executives allegedly made numerous false and misleading statements to investors during the Class Period.

DENTSPLY SIRONA INC. (NASDAQ: XRAY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

Retrieved on: 
Tuesday, July 12, 2022
Lists of action films, Technology, Achievement, Class, SEC, Audit, Labour government, Plaque, Degenerative disease, News, Advertising, Company, Securities Exchange Act of 1934, Committee on Finance, NEW, GLOBE, COVID-19, Investment, The Legal 500, Disclosure, Anesthetic, Defendant, Audit committee, XRAY, Board, Court, District court, Board of directors, Sirona, NASDAQ, Dentsply Sirona, Tobacco, Security (finance)

NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Ohio and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Dentsply produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
  • As (former) executives of Dentsply, Defendants Donald M. Casey, Jr. (Casey) and Jorge Gomez (Gomez) were eligible for significant cash- and stock-based incentive compensation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP, and Dentsply Sirona and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, July 11, 2022
FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, HBR, Defendant, Treatment, Superior, Mission statement, Review, New Drug Application, GLOBE, Degenerative disease, Medicare, Lists of schools in England, Spero, Plaque, News, Population, NDA, Class Action, LMP, Tebipenem, Marketing, Government, Income, Relevant, Patient, SEC, Growth, Complicated, Physician, California superior courts, XRAY, Infection, Annual report, Urinary tract infection, Audit committee, CDNA, Justice, Food, Company, ASP, Dentsply Sirona, Anesthetic, Workforce, Kidney, COVID-19, Risk, Sale, Board, Documentation, NASDAQ, Complaint, Pharmaceutical industry, Animal, Renewable energy, Audit, Medical device, Property management, Pyelonephritis, P.C

Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.

Key Points: 
  • Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the Class Period.
  • For more information on the Dentsply Sirona class action go to: https://bespc.com/cases/XRAY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages DENTSPLY SIRONA Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY

Retrieved on: 
Sunday, July 10, 2022
Titan, XRAY, I-Space (Chinese company), Advertising, LinkedIn, Court, TO, Sirona, WHY, Class, Lists of schools in England, GAAP, THE, SEC, Facebook, NASDAQ, Dentsply Sirona, Twitter, Security (finance), Insurance, Tobacco

WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=6111 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY

Retrieved on: 
Saturday, July 9, 2022
GLOBE, XRAY, NASDAQ, News, Dentsply Sirona, LLP, Company, Pomerantz, Private investigator

NEW YORK, July 09, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (Dentsply Sirona or the Company) (NASDAQ: XRAY).

Key Points: 
  • NEW YORK, July 09, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dentsply Sirona Inc. (Dentsply Sirona or the Company) (NASDAQ: XRAY).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Dentsply Sirona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Dentsply Sirona Inc. (XRAY)

Retrieved on: 
Thursday, July 7, 2022
XRAY, Defendant, Court, GLOBE, Company, Suite, Lists of schools in England, Mission statement, GPM, NASDAQ, Time, News, Dentsply Sirona

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, Dentsplys stock fell $6.52, or 13.4%, to close at $42.20 per share on April 19, 2022, thereby injuring investors.
  • On this news, Dentsplys stock fell $2.87, or 7.3%, to close at $36.38 on May 10, 2022, thereby injuring investors further.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.